AHL Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $8.21M | Buy |
114,529
+25,119
| +28% | +$1.8M | 0.13% | 288 |
|
|
2017
Q3 | $7.24M | Buy |
89,410
+19,183
| +27% | +$1.55M | 0.13% | 283 |
|
|
2017
Q2 | $4.97M | Buy |
70,227
+11,337
| +19% | +$802K | 0.11% | 353 |
|
|
2017
Q1 | $4M | Buy |
58,890
+15,839
| +37% | +$1.08M | 0.09% | 413 |
|
|
2016
Q4 | $3.08M | Buy |
43,051
+23,692
| +122% | +$1.7M | 0.09% | 397 |
|
|
2016
Q3 | $1.53M | Buy |
19,359
+7,021
| +57% | +$555K | 0.06% | 460 |
|
|
2016
Q2 | $1.03M | Buy |
12,338
+4,391
| +55% | +$366K | 0.06% | 430 |
|
|
2016
Q1 | $730K | Sell |
7,947
-21,302
| -73% | -$1.96M | 0.05% | 470 |
|
|
2015
Q4 | $2.96M | Buy |
29,249
+22,756
| +350% | +$2.3M | 0.23% | 154 |
|
|
2015
Q3 | $638K | Sell |
6,493
-40,220
| -86% | -$3.95M | 0.1% | 288 |
|
|
2015
Q2 | $5.47M | Sell |
46,713
-9,729
| -17% | -$1.14M | 0.22% | 142 |
|
|
2015
Q1 | $5.54M | Buy |
56,442
+29,811
| +112% | +$2.93M | 0.22% | 129 |
|
|
2014
Q4 | $2.51M | Buy |
26,631
+24,398
| +1,093% | +$2.3M | 0.13% | 345 |
|
|
2014
Q3 | $238K | Buy |
+2,233
| New | +$238K | 0.02% | 657 |
|